substance p has been researched along with Bowel Diseases, Inflammatory in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (33.33) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 9 (30.00) | 24.3611 |
| 2020's | 3 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arifuzzaman, M; Artis, D; Bessman, NJ; Chu, C; Guo, CJ; Hu, H; Jin, WB; Li, TT; Lyu, M; Parkhurst, CN; Putzel, GG; Tsou, AM; Xie, Z; Yano, H; Zhang, W; Zhou, J; Zhou, L | 1 |
| Calka, J; Gonkowski, S; Kaczmar, E; Makowska, K; Rychlik, A | 1 |
| Boerman, EM; Franklin, CL; Grunz-Borgmann, EA; Hart, ML; Jones, BW; Norton, CE | 1 |
| El-Salhy, M; Gilja, OH; Hatlebakk, JG; Hausken, T; Solomon, T | 1 |
| Akasheh, N; Costello, RW; Cummins, R; Gleich, GJ; Kay, E; Morgan, RK; Murray, FM; O'Grady, A; Sheils, O; Smyth, CM; Smyth, P; Thornton, MA; Woods, S | 1 |
| Weinstock, JV | 2 |
| Cavalcoli, F; Conte, D; Massironi, S; Peracchi, M; Zilli, A | 1 |
| Hong, HS; Hwang, DY; Kim, S; Park, JH; Seo, EJ; Son, Y | 1 |
| Ansorge, S; Bank, U; Bohr, UR; Lendeckel, U; Malfertheiner, P; Reinhold, D; Tager, M | 1 |
| Karagiannides, I; Pothoulakis, C | 1 |
| Beinborn, M; Blum, A; Hang, L; Leung, J; Schroeder, JC; Setiawan, T; Stoyanoff, K; Weinstock, JV | 1 |
| Becker, C; Engel, MA; Khalil, M; Mueller-Tribbensee, SM; Neuhuber, WL; Neurath, MF; Reeh, PW; Siklosi, N | 1 |
| Bian, ZX; Sung, JJ; Tsang, SW; Wu, J; Zhao, M | 1 |
| Andriulli, A; Annese, V; Bossa, F; di Mola, FF; di Sebastiano, P; Latiano, A; Latiano, T; Palmieri, O; Tavano, F; Valvano, MR | 1 |
| Koon, HW; Pothoulakis, C | 1 |
| Blum, AM; Ferraris, L; Fiocchi, C; Klein, JS; Metwali, A; Weinstock, JV | 1 |
| Bollinger, RR; Maggio, JE; Mantyh, CR; Mantyh, PW; Pappas, TN; Vigna, SR | 1 |
| Kiyono, H; McGhee, JR; Pascual, DW | 1 |
| Welton, ML | 1 |
| Anton, PA; Shanahan, F | 1 |
| Anton, PA | 1 |
| Sands, BE | 1 |
| Collins, SM | 1 |
| Corbett, AD; McKee, R; Menzies, JR | 1 |
| Baird, AW; Goldhill, J; Moriarty, D; O'Donoghue, DP; Selve, N | 1 |
| Holzer, P; Holzer-Petsche, U | 1 |
| Sharkey, KA | 1 |
| Das, KM; Mazumdar, S | 1 |
| Mantyh, PW | 1 |
16 review(s) available for substance p and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.
Topics: Amines; Animals; Chromogranins; Disease Models, Animal; Gastrointestinal Microbiome; Gastrointestinal Tract; Ghrelin; Humans; Inflammatory Bowel Diseases; Neuroendocrine Cells; Neuropeptide Y; Neurosecretory Systems; Prevalence; Quality of Life; Recurrence; Serotonin; Serotonin Antagonists; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2017 |
Substance P and the regulation of inflammation in infections and inflammatory bowel disease.
Topics: Animals; Cytokines; Humans; Infections; Inflammatory Bowel Diseases; Receptors, Neurokinin-1; Substance P; T-Lymphocytes | 2015 |
Chromogranin A and other enteroendocrine markers in inflammatory bowel disease.
Topics: Animals; Biomarkers; Chromogranin A; Enteroendocrine Cells; Ghrelin; Humans; Inflammatory Bowel Diseases; Neurotensin; Serotonin; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2016 |
Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors.
Topics: Brain; CD13 Antigens; Colitis, Ulcerative; Dipeptidyl-Peptidase IV Inhibitors; Gastrointestinal Tract; Humans; Inflammatory Bowel Diseases; Protease Inhibitors; Substance P; T-Lymphocyte Subsets; Vasoactive Intestinal Peptide | 2008 |
Substance P, obesity, and gut inflammation.
Topics: Adipose Tissue; Developed Countries; Gastrointestinal Diseases; Humans; Inflammation; Inflammatory Bowel Diseases; Obesity; Substance P | 2009 |
The role of substance P, hemokinin and their receptor in governing mucosal inflammation and granulomatous responses.
Topics: Animals; Chronic Disease; Gastroenteritis; Granuloma; Hepatitis; Humans; Immunity, Mucosal; Inflammation; Inflammatory Bowel Diseases; Mice; Protein Precursors; Receptors, Neurokinin-1; Substance P; Tachykinins | 2004 |
Immunomodulatory properties of substance P: the gastrointestinal system as a model.
Topics: Animals; Gastroenteritis; Gastrointestinal Tract; Humans; Inflammatory Bowel Diseases; Neuroimmunomodulation; Substance P | 2006 |
The enteric nervous and immune systems: interactions for mucosal immunity and inflammation.
Topics: Animals; Enteric Nervous System; Humans; Immunoglobulin A; Immunologic Memory; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Mice; Neuroimmunomodulation; Neuropeptides; Peyer's Patches; Rats; Receptors, Neuropeptide; Substance P; Th2 Cells; Vasoactive Intestinal Peptide | 1994 |
Human colonic microvascular endothelial cells is a model of inflammatory bowel disease.
Topics: Bradykinin; Colon; Endothelial Growth Factors; Endothelium, Vascular; Humans; Inflammatory Bowel Diseases; Microcirculation; Models, Biological; Substance P | 1997 |
Neuroimmunomodulation in inflammatory bowel disease. How far from "bench" to "bedside"?
Topics: Humans; Immune System; Inflammatory Bowel Diseases; Intestinal Mucosa; Nervous System; Neuroimmunomodulation; Pain Threshold; Receptors, Neurokinin-1; Stress, Psychological; Substance P; Tomography, Emission-Computed | 1998 |
Stress and mind-body impact on the course of inflammatory bowel diseases.
Topics: Adult; Colitis, Ulcerative; Crohn Disease; Humans; Hypothalamo-Hypophyseal System; Inflammatory Bowel Diseases; Male; Pituitary-Adrenal System; Placebo Effect; Receptors, Neurokinin-1; Stress, Psychological; Substance P | 1999 |
Novel therapies for inflammatory bowel disease.
Topics: Anti-Bacterial Agents; CD4-Positive T-Lymphocytes; Cytokines; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-10; Lysosomal Membrane Proteins; Membrane Glycoproteins; NF-kappa B; Somatostatin; Substance P; Tumor Necrosis Factor-alpha | 1999 |
Stress and the Gastrointestinal Tract IV. Modulation of intestinal inflammation by stress: basic mechanisms and clinical relevance.
Topics: Animals; Arginine Vasopressin; Capillary Permeability; Colonic Diseases, Functional; Corticotropin-Releasing Hormone; Humans; Inflammatory Bowel Diseases; Mice; Rats; Stress, Physiological; Substance P | 2001 |
Tachykinin receptors in the gut: physiological and pathological implications.
Topics: Animals; Colonic Diseases, Functional; Digestive System; Digestive System Physiological Phenomena; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Inflammatory Bowel Diseases; Neurokinin A; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Receptors, Tachykinin; Substance P | 2001 |
Substance P and calcitonin gene-related peptide (CGRP) in gastrointestinal inflammation.
Topics: Afferent Pathways; Animals; Calcitonin Gene-Related Peptide; Digestive System; Enteritis; Humans; Inflammatory Bowel Diseases; Substance P; Tissue Distribution | 1992 |
Substance P and the inflammatory and immune response.
Topics: Animals; Central Nervous System; Humans; Immune System; Inflammation; Inflammatory Bowel Diseases; Neurons; Receptors, Neurokinin-1; Receptors, Neurotransmitter; Substance P | 1991 |
14 other study(ies) available for substance p and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Gut-innervating nociceptors regulate the intestinal microbiota to promote tissue protection.
Topics: Animals; Dysbiosis; Gastrointestinal Microbiome; Inflammation; Inflammatory Bowel Diseases; Mice; Nociceptors; Substance P | 2022 |
Changes in the expression of substance P in nerve fibres of the colonic mucosa in dogs suffering from inflammatory bowel disease.
Topics: Animals; Colon; Dog Diseases; Dogs; Female; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Nerve Fibers; Substance P | 2020 |
Role of perivascular nerve and sensory neurotransmitter dysfunction in inflammatory bowel disease.
Topics: Animals; Calcitonin Gene-Related Peptide; Disease Models, Animal; Female; Helicobacter hepaticus; Inflammatory Bowel Diseases; Interleukin-10; Male; Mesenteric Arteries; Mice, Inbred C57BL; Mice, Knockout; Receptors, Calcitonin Gene-Related Peptide; Receptors, Neurokinin-1; Sensory Receptor Cells; Signal Transduction; Splanchnic Circulation; Substance P; Sympathetic Nervous System; Vasoconstriction; Vasodilation | 2021 |
Activated eosinophils in association with enteric nerves in inflammatory bowel disease.
Topics: Base Sequence; Choline O-Acetyltransferase; DNA Primers; Enteric Nervous System; Eosinophils; Humans; Inflammatory Bowel Diseases; Real-Time Polymerase Chain Reaction; Substance P; Transforming Growth Factor beta | 2013 |
Substance-P alleviates dextran sulfate sodium-induced intestinal damage by suppressing inflammation through enrichment of M2 macrophages and regulatory T cells.
Topics: Animals; Dextran Sulfate; Inflammation; Inflammatory Bowel Diseases; Interleukin-17; Intestinal Mucosa; Intestines; Macrophages; Male; Mice; Substance P; Tumor Necrosis Factor-alpha | 2017 |
TGF-beta regulates T-cell neurokinin-1 receptor internalization and function.
Topics: Animals; Cell Line; Endocytosis; Flow Cytometry; Humans; Inflammatory Bowel Diseases; Interleukin-10; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Receptors, Neurokinin-1; Signal Transduction; Substance P; T-Lymphocytes; Transforming Growth Factor beta | 2010 |
Opposite effects of substance P and calcitonin gene-related peptide in oxazolone colitis.
Topics: Animals; Calcitonin Gene-Related Peptide; Colitis; Colon; Cytokines; Enzyme-Linked Immunosorbent Assay; Inflammatory Bowel Diseases; Mice; Mice, Knockout; Oxazolone; Substance P | 2012 |
Nerve growth factor-mediated neuronal plasticity in spinal cord contributes to neonatal maternal separation-induced visceral hypersensitivity in rats.
Topics: Animals; Animals, Newborn; Anxiety, Separation; Blotting, Western; Calcitonin Gene-Related Peptide; Carbazoles; Female; Fluorescent Antibody Technique; Gastrointestinal Diseases; Hyperalgesia; Indole Alkaloids; Inflammatory Bowel Diseases; Injections, Intraperitoneal; Male; Maternal Deprivation; Nerve Growth Factor; Neuronal Plasticity; Pain Measurement; Pregnancy; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Nerve Growth Factor; Receptor, trkA; Spinal Cord; Substance P | 2012 |
Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levels.
Topics: Adolescent; Adult; Aged; Biomarkers; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Neuroimmunomodulation; ROC Curve; Severity of Illness Index; Substance P; Time Factors; Young Adult | 2012 |
Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide.
Topics: Adolescent; Adult; Base Sequence; Cells, Cultured; Child; Eosinophils; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Middle Aged; Molecular Sequence Data; RNA, Messenger; Substance P; Vasoactive Intestinal Peptide | 1994 |
Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic NK-1 receptors.
Topics: Binding Sites; Biphenyl Compounds; Blood Vessels; Humans; Indoles; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Isoindoles; Lymphoid Tissue; Neurokinin-1 Receptor Antagonists; Quinuclidines; Receptors, Neurokinin-1; Substance P | 1994 |
Differential alterations in tachykinin NK2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation.
Topics: Adult; Aged; Aged, 80 and over; Carbachol; Cholinergic Agonists; Chronic Disease; Colon; Constipation; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Receptors, Neurokinin-2; Receptors, Tachykinin; Substance P | 2001 |
Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease.
Topics: Animals; Antidiarrheals; Capsaicin; Colitis, Ulcerative; Colon; Crohn Disease; Epithelial Cells; Food Hypersensitivity; Guinea Pigs; Humans; Immunoglobulin E; Inflammatory Bowel Diseases; Male; Mast Cells; Neurokinin A; Neurokinin B; Neurokinin-1 Receptor Antagonists; Piperidines; Quinuclidines; Rats; Receptors, Neurokinin-1; Species Specificity; Substance P; Tachykinins | 2001 |
Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.
Topics: Colitis, Ulcerative; Colon; Crohn Disease; Humans; Immunoenzyme Techniques; Inflammatory Bowel Diseases; Reference Values; Substance P; Vasoactive Intestinal Peptide | 1992 |